Can This Biomarker-Based Screening Identify More Early-Stage Lung Cancers? - Cancer Network

Can This Biomarker-Based Screening Identify More Early-Stage Lung Cancers?  Cancer Network

The EarlyCDT-Lung test of several blood biomarkers was able to reduce the number of late-stage lung cancers compared to standard care in a screening trial of ...



Comments

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Mechanism and clinical progression of solid tumors bone marrow metastasis

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions